Holen Sie sich die Stockscreener-App
0.8009
12.66%
-0.1092
Handel nachbörslich:
.80
-0.0009
-0.11%
Schlusskurs vom Vortag:
$0.9101
Offen:
$0.9
24-Stunden-Volumen:
3.77M
Relative Volume:
4.16
Marktkapitalisierung:
$47.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-123.46M
KGV:
-0.3092
EPS:
-2.59
Netto-Cashflow:
$-104.11M
1W Leistung:
-0.01%
1M Leistung:
+2.58%
6M Leistung:
+152.11%
1J Leistung:
-60.45%
1-Tages-Spanne:
$0.6953
$0.91
1-Wochen-Bereich:
$0.6953
$1.06
52-Wochen-Spanne:
$0.2601
$2.525
Bioatla Inc Stock (BCAB) Company Profile
Firmenname
Bioatla Inc
Sektor
Branche
Telefon
858-558-0708
Adresse
11085 TORREYANA ROAD, SAN DIEGO
Vergleichen Sie BCAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.8009 | 53.44M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Bioatla Inc Stock (BCAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-11-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-05-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-28 | Eingeleitet | ROTH Capital | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | BTIG Research | Buy |
| 2021-01-11 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-01-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Bioatla Inc Aktie (BCAB) Neueste Nachrichten
Will BioAtla Inc. continue its uptrendJuly 2025 Movers & Reliable Volume Spike Alerts - newser.com
Published on: 2025-10-14 04:44:51 - newser.com
Understanding BioAtla Inc.’s price movementWeekly Earnings Recap & AI Driven Stock Price Forecasts - newser.com
Why BioAtla Inc. stock is rated strong buySwing Trade & Community Verified Trade Signals - newser.com
Will BioAtla Inc. stock keep outperforming rivalsPortfolio Return Report & Smart Allocation Stock Tips - newser.com
How supply chain issues affect BioAtla Inc. stockProfit Target & Daily Technical Stock Forecast Reports - newser.com
Why BioAtla Inc. stock is favored by top institutionsPortfolio Gains Report & Verified Stock Trade Ideas - newser.com
Strategies to average down on BioAtla Inc.2025 Support & Resistance & Verified Swing Trading Watchlists - newser.com
How to use a screener to detect BioAtla Inc. breakoutsWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
Is BioAtla Inc. reversing from oversold territoryJuly 2025 Recap & Verified Swing Trading Watchlist - newser.com
Real time breakdown of BioAtla Inc. stock performancePrice Action & Low Drawdown Momentum Ideas - newser.com
Order flow analysis tools used on BioAtla Inc.Quarterly Profit Report & Weekly High Conviction Ideas - newser.com
How institutional ownership impacts BioAtla Inc. stockJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
Technical signs of recovery in BioAtla Inc.Portfolio Performance Report & Low Drawdown Investment Strategies - newser.com
What’s next for BioAtla Inc. stock priceEarnings Miss & Long-Term Growth Plans - newser.com
Applying Elliott Wave Theory to BioAtla Inc.Bull Run & Weekly High Momentum Picks - newser.com
Why BioAtla Inc. stock could outperform in 2025Risk Management & Expert Approved Momentum Trade Ideas - newser.com
Will BioAtla Inc. stock recover after recent dropJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - newser.com
Can technical indicators confirm BioAtla Inc.’s reversalWeekly Stock Recap & High Return Stock Watch Alerts - newser.com
Historical volatility pattern of BioAtla Inc. visualizedMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Should you wait for a breakout in BioAtla Inc.Bond Market & Community Shared Stock Ideas - newser.com
Can momentum traders help lift BioAtla Inc.2025 Volume Leaders & Growth Focused Entry Reports - newser.com
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025 - GlobeNewswire
BioAtla, Inc. to Present Clinical Data on AXL-Targeting ADC Mecbotamab Vedotin at SITC 2025 Annual Meeting - Quiver Quantitative
Median OS 21.5 months: BioAtla presents mecbotamab vedotin data in 44 sarcoma patients at SITC - Stock Titan
Detecting price anomalies in BioAtla Inc. with AIWeekly Trading Summary & Risk Managed Investment Strategies - newser.com
Real time alert setup for BioAtla Inc. performanceJuly 2025 Reactions & Technical Entry and Exit Alerts - newser.com
Finanzdaten der Bioatla Inc-Aktie (BCAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):